Introduction and Objective: Polygenic risk scores (PRS) are emerging as a novel tool for prevention and management of cardio-renal-metabolic (CRM) disease. In this study, we describe results from the first year of implementing clinical PRS testing for CRM disease in a large community health system.Methods: CLIA-certified PRS testing for type 1 diabetes, type 2 diabetes, […]
Read MoreMonth: July 2025
2121-LB: PanKbase Integrated Single-Cell Map—A Comprehensive Atlas of Human Pancreatic Islets Unlocking Insights into Type 1 and Type 2 Diabetes
Introduction and Objective: Single-cell RNA sequencing (scRNA-seq) analysis of pancreatic islet tissues is powerful for studying Type 1 and Type 2 Diabetes (T1D and T2D). Despite many existing efforts, individual datasets are modest in size and fragmented across donors, labs and conditions, highlighting the need for a single-cell (SC) atlas that collates information from diverse […]
Read More538-P: Leadership and Change Management in Diabetes Education—Addressing Health Literacy and Health Disparities in the Diabetes Belt
Introduction and Objective: The Diabetes Belt, spanning 644 counties across 15 southern states, faces disproportionately high rates of type 2 diabetes, compounded by limited health literacy and systemic inequities. This study investigates how health educators employ leadership and behavior change theories—transformational leadership, transactional leadership, the transtheoretical model, and diffusion of innovation—to design effective interventions. The […]
Read More151-OR: Comparison of WBC SPECT/CT and MRI in Diagnosis and Treatment Response of Diabetic Foot Osteomyelitis Using Paired Biopsies as Reference Standard
Introduction and Objective: The objective of this study was to compare the performance of Tc-99m WBC SPECT/CT and MRI in subjects with suspected diabetic foot osteomyelitis (DFO) using bone biopsy as a reference standard.Methods: In total, 47 subjects with suspected DFO underwent MRI and Tc-99m WBC SPECT/CT imaging prior to bone biopsy. Subjects with soft […]
Read More1397-P: Real-World Evidence on the Legacy Effect of Early vs. Late Glycaemic Reduction and All-Cause Mortality in Newly Diagnosed Type 2 Diabetes
Introduction and Objective: While clinical trials have established legacy effects in diabetes management, real-world evidence on how historical glycaemic exposures affect survival and critical time windows is limited. We evaluated the legacy effect of glycaemic exposure on all-cause mortality among newly diagnosed type 2 diabetes (T2D).Methods: This was a retrospective cohort of 52,404 newly diagnosed […]
Read More392-P: Metabotypes to Define Cardiorenal Risk in People with Type 1 Diabetes
Introduction and Objective: Cardio-renal complications are the leading source of morbidity in people with type 1 diabetes (T1D). While previous metabolomic studies have characterized incident and predictive metabolic signatures (metabotypes) of diabetic kidney disease (DKD) and cardiovascular autonomic neuropathy (CAN) in separate T1D cohorts, no previous study has investigated CAN and DKD in the same […]
Read More1394-P: Rising Burden of Diabetes and Chronic Kidney Disease Attributable to Sugar-Sweetened Beverages among Young Adults—A Global Analysis and 30-Year Projection (1990–2051)
Introduction and Objective: Sugar-sweetened beverages (SSBs) consumption has emerged as a critical public health concern globally. However, comprehensive analysis of its long-term impact on diabetes mellitus and chronic kidney disease (CKD) mortality across different socio-demographic contexts remains limited.Methods: Using Global Burden of Disease Study 2021 data, we analyzed SSB-attributable diabetes and CKD mortality trends across […]
Read More1395-P: Evaluating the Predictive Value of Emerging Indices (WHtR, Tyg-WHtR) vs. Traditional Markers (BMI, TyG Index, TG/HDL, Non-HDL/HDL) for MASLD Severity in People with Diabetes Using Fast Scores
Introduction and Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) with diabetes has grave health implications. The FAST score is a widely used tool for assessing MASLD severity. However, its relationship with indices such as TyG INDEX, TyGWHtR, BMI, and WHtR remains unclear. This study evaluated the predictive value of these indices for MASLD severity using […]
Read More377-P: Diabetes Reduces Endothelial Glycocalyx via Matrix Remodeling
Introduction and Objective: Diabetic Kidney Disease (DKD) occurs commonly in people with diabetes and often presents with albuminuria resulting from glomerular filtration barrier injury. The glycocalyx, an extracellular matrix (ECM) produced by endothelial cells, plays a critical role in regulating glomerular filtration.Methods: To test if diabetes induces ECM changes, we examined the abundance of glomerular […]
Read More1392-P: Emergency Hospitalization of Young-Onset Type 1 and 2 Diabetes—Data from the Korean National Health Insurance Service
Introduction and Objective: To explore the incidence of emergency hospitalization among young-onset diabetes using a nationwide registry database.Methods: Based on the Korean National Health Insurance Service-National Sample Cohort database from 2006 to 2019, data were collected for patients aged ≤30 years with type 1 (T1D) and type 2 diabetes (T2D). The risks of emergency hospitalization […]
Read More